characteristics of the included studies - part 2
| Reference | Included Population | Optimal Cytoreduction Criterion (RT, cm) | Optimal Cytoreduction (%) | Complete Cytoreduction (%) | Outcome Measure | Median Survival OC (months) | Median Survival SOC (months) | P Value | Median Survival RT=0 (months) |
|---|---|---|---|---|---|---|---|---|---|
| Hizli, 2012 | 23 | <1 | 65.2 | NA | OS, TFS | 14 (TFS) | 0 (TFS) | 0.018 | NA |
| Fotopoulou, 2012 | 406 | 0 | 54.4 | - | OS, PFS | 49 (OS) | 12 (OS) | <0.001 | - |
| Tang, 2013 | 83 | 0 | 70 | - | OS | 32.9 | 14.6 | 0.001 | - |
| Fanfani, 2015 | 46 | <1 | 1.9 | 77.5 | PFS, OS | NA | NA | NS | 22 (PFS), 99 (OS) |
| Arvas, 2016 | 53 | <0.5 | 49 | NA | OS, DSS | 40 (DSS) | 18 (DSS) | 0.003 | NA |
| Falcone, 2017 | 135 | 0 | 68.9 | - | OS | 43 | 33 | <0.001 | - |
OC, Optimal Cytoreduction; SOC, Suboptimal Cytoreduction; RT, Residual Tumor